55,412 Shares in Cabot Corporation $CBT Acquired by Deutsche Bank AG

Deutsche Bank AG bought a new stake in Cabot Corporation (NYSE:CBTFree Report) during the 2nd quarter, Holdings Channel.com reports. The firm bought 55,412 shares of the specialty chemicals company’s stock, valued at approximately $5,033,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Torren Management LLC bought a new stake in shares of Cabot in the 4th quarter valued at $26,000. Rothschild Investment LLC grew its holdings in Cabot by 170.4% during the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 259 shares during the period. Global Retirement Partners LLC raised its position in shares of Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after acquiring an additional 466 shares in the last quarter. Geneos Wealth Management Inc. lifted its stake in shares of Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 364 shares during the period. Finally, Danske Bank A S acquired a new position in shares of Cabot in the 3rd quarter valued at about $38,000. Institutional investors own 93.18% of the company’s stock.

Wall Street Analysts Forecast Growth

CBT has been the subject of a number of research analyst reports. Mizuho lifted their target price on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, June 25th. JPMorgan Chase & Co. raised their price objective on shares of Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research report on Friday, August 7th. UBS Group lowered their price objective on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research note on Wednesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Friday. Finally, Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Two analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $89.00.

Check Out Our Latest Stock Analysis on Cabot

Insider Buying and Selling at Cabot

In related news, CEO Sean D. Keohane sold 91,923 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $86.41, for a total value of $7,943,066.43. Following the completion of the transaction, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at approximately $34,921,218.94. This trade represents a 18.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.08% of the stock is owned by insiders.

Cabot Price Performance

CBT opened at $83.76 on Wednesday. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $94.53. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The company has a market capitalization of $4.32 billion, a price-to-earnings ratio of 23.59, a P/E/G ratio of 10.89 and a beta of 0.84. The firm’s fifty day moving average price is $87.99 and its two-hundred day moving average price is $81.05.

Cabot (NYSE:CBTGet Free Report) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.01. The company had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.Cabot’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, analysts anticipate that Cabot Corporation will post 6.37 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio (DPR) is currently 53.24%.

About Cabot

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Further Reading

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.